LFT-Liver Functions Tests at Biotech Lahore Lab

LFT-Liver Functions Tests at Biotech Lahore Lab

Liver Function Tests (LFTs) are essential biochemical investigations designed to assess the physiological state, synthetic capacity, and excretory performance of the liver. At Biotech Lahore Lab in Lahore, Pakistan, this comprehensive blood panel is performed using state-of-the-art automated clinical chemistry analyzers to deliver highly precise and clinically actionable results. The liver is a vital organ responsible for metabolic regulation, detoxification of endogenous and exogenous compounds, protein synthesis, and bile production. When hepatocytes are damaged or biliary flow is obstructed, specific enzymes and proteins are released into the bloodstream. Measuring these biomarkers allows clinicians to detect, evaluate, and monitor a wide spectrum of hepatic and systemic disorders.

The standard LFT panel at Biotech Lahore Lab evaluates several key parameters, including Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Alkaline Phosphatase (ALP), Gamma-Glutamyl Transferase (GGT), Total Bilirubin, Direct (Conjugated) Bilirubin, Indirect (Unconjugated) Bilirubin, Total Protein, Albumin, and the Albumin-to-Globulin (A/G) ratio. Each of these biomarkers provides unique insights into different aspects of hepatic pathophysiology. For instance, elevated transaminases (ALT and AST) typically signal hepatocellular injury, whereas elevations in ALP and GGT point toward cholestatic patterns or biliary tract obstruction. Synthetic function is primarily reflected in serum albumin levels and the prothrombin time (often ordered in conjunction with LFTs), as the liver is the sole site of albumin production. Understanding these parameters helps healthcare providers differentiate between acute liver injury, chronic liver disease, biliary tract disorders, and systemic conditions affecting the liver.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest level of diagnostic accuracy and prevent pre-analytical errors, patients undergoing Liver Function Tests (LFTs) at Biotech Lahore Lab must follow specific preparation guidelines:

• Fasting Requirements: Patients are generally advised to fast for 8 to 12 hours before the blood draw. Fasting is particularly crucial because eating can alter serum levels of certain enzymes and bile pigments, especially bilirubin and alkaline phosphatase. Only plain water is permitted during this fasting period.
• Medication Review: Inform your prescribing physician and the laboratory staff about all medications, over-the-counter drugs, herbal supplements, and vitamins you are currently taking. Certain medications (such as statins, acetaminophen, antibiotics, and antiepileptic drugs) can transiently elevate liver enzymes. Do not stop prescribed medications without consulting your doctor.
• Alcohol Avoidance: Patients must strictly avoid alcohol consumption for at least 24 to 48 hours prior to the test, as alcohol can cause acute fluctuations in GGT and transaminase levels.
• Hydration: Staying adequately hydrated by drinking plain water is highly recommended, as it makes venous access easier for the phlebotomist.

During the Procedure

The collection of a blood sample for LFTs at Biotech Lahore Lab is a routine, safe, and quick venipuncture procedure performed by highly trained phlebotomists. The entire process typically takes less than five minutes:

• Positioning: The patient is comfortably seated in a specialized phlebotomy chair. The phlebotomist asks the patient to extend their arm, exposing the antecubital fossa (the inner elbow area).
• Site Selection and Sanitization: The phlebotomist palpates the veins to select the most suitable vessel, usually the median cubital vein. The selected site is thoroughly cleansed with an antiseptic swab (70% isopropyl alcohol) and allowed to air dry to prevent hemolysis of the sample.
• Tourniquet Application: A sterile elastic tourniquet is applied a few inches above the puncture site to increase venous pressure, making the vein more visible and accessible.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube (typically a gold-top serum separator tube or red-top clot activator tube) is gently inserted into the vein. Patients may feel a brief, mild pinch or prick.
• Sample Collection: As the blood flows into the tube, the tourniquet is released to restore normal circulation. Once the required volume of blood is collected, the needle is smoothly withdrawn.
• Post-Puncture Care: Immediate, gentle pressure is applied to the puncture site with a sterile cotton ball or gauze pad to promote hemostasis. A small adhesive bandage is then applied. Patients are advised to keep the bandage on for at least 1 to 2 hours and avoid heavy lifting with that arm for the rest of the day.

When is a LFT-Liver Functions Tests Performed?

Screening for Hepatic Inflammation and Hepatitis

Physicians frequently request Liver Function Tests when a patient presents with risk factors or symptoms of hepatitis. Viral infections (such as Hepatitis A, B, C, D, and E), autoimmune disorders, and heavy alcohol consumption can cause acute or chronic inflammation of the liver parenchyma. LFTs help detect early-stage inflammation, often before significant clinical symptoms manifest, by revealing elevated transaminase levels (ALT and AST) which leak from damaged hepatocytes into the systemic circulation.

Evaluating Symptoms of Hepatobiliary Disease

When patients present with clinical signs suggestive of hepatobiliary pathology, LFTs are indicated as a primary diagnostic tool. Key clinical symptoms include jaundice (yellowing of the skin and sclera), dark tea-colored urine, pale or clay-colored stools, unexplained pruritus (itching), abdominal pain localized to the right upper quadrant, persistent nausea, vomiting, and unexplained fatigue. By analyzing the balance of bilirubin and biliary enzymes (ALP and GGT), clinicians can localize the issue to either the liver cells or the biliary drainage system.

Monitoring Hepatotoxic Medications

Many commonly prescribed medications, including lipid-lowering statins, nonsteroidal anti-inflammatory drugs (NSAIDs), certain antibiotics, antifungal agents, and antiepileptic drugs, carry a risk of drug-induced liver injury (DILI). For patients initiated on these therapeutic regimens, physicians order baseline LFTs followed by periodic monitoring at Biotech Lahore Lab. This proactive approach ensures that any subclinical hepatotoxicity is detected early, allowing for timely dosage adjustments or drug discontinuation before irreversible liver damage occurs.

Assessing Chronic Medical Conditions

Patients diagnosed with chronic systemic conditions such as type 2 diabetes, obesity, metabolic syndrome, cardiovascular disease, or autoimmune disorders are at an increased risk of developing Non-Alcoholic Fatty Liver Disease (NAFLD) or its progressive form, Non-Alcoholic Steatohepatitis (NASH). Regular LFT monitoring assists healthcare providers in tracking liver health in these high-risk populations, facilitating early lifestyle interventions or therapeutic management to prevent progression to hepatic fibrosis and cirrhosis.

Monitoring Known Liver Diseases and Treatment Efficacy

For patients with established liver diagnoses, such as cirrhosis, alcoholic liver disease, hemochromatosis, Wilson’s disease, or chronic viral hepatitis, LFTs are performed at regular intervals. These serial measurements allow gastroenterologists and hepatologists to assess the progression of the disease, evaluate the patient’s prognosis, and determine the therapeutic efficacy of ongoing treatments, such as antiviral therapies or immunosuppressive regimens.

What Does a LFT-Liver Functions Tests Detect?

Liver Function Tests are highly sensitive diagnostic indicators that can detect a wide range of acute and chronic pathophysiological states, including:

• Acute Hepatocellular Injury: Marked elevations in ALT and AST (often exceeding 10 times the upper limit of normal) typically point to acute viral hepatitis, toxic insults (such as acetaminophen overdose), or ischemic hepatitis (shock liver).
• Chronic Hepatocellular Damage: Mild to moderate elevations in transaminases are frequently seen in chronic hepatitis B or C, non-alcoholic fatty liver disease (NAFLD), and alcoholic liver disease.
• Cholestasis and Biliary Obstruction: Significantly elevated levels of Alkaline Phosphatase (ALP) and Gamma-Glutamyl Transferase (GGT), accompanied by elevated direct bilirubin, indicate impaired bile flow. This can be caused by gallstones, biliary strictures, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), or pancreatic head tumors.
• Impaired Synthetic Function: Decreased levels of serum albumin and total protein suggest compromised hepatic synthetic capacity, which is characteristic of advanced liver cirrhosis, end-stage liver disease, or severe nutritional deficiencies.
• Hyperbilirubinemia: Elevated total bilirubin levels can be classified into conjugated (direct) or unconjugated (indirect) hyperbilirubinemia. Conjugated hyperbilirubinemia points to hepatobiliary excretion issues, while unconjugated hyperbilirubinemia often indicates hemolytic disorders (excessive red blood cell breakdown) or genetic conditions like Gilbert’s syndrome.
• Alcohol-Induced Liver Pathology: An isolated, significant elevation in GGT, especially when the AST to ALT ratio is greater than 2:1, is highly suggestive of alcohol-induced liver injury or chronic alcohol abuse.
• Systemic Inflammatory and Infiltrative Diseases: Infiltrative disorders of the liver, such as sarcoidosis, amyloidosis, tuberculosis, or metastatic liver disease, often present with isolated elevations in ALP with relatively normal transaminases.

Turnaround Time and Report Access at Biotech Lahore Lab

At Biotech Lahore Lab, we understand that timely diagnostic results are crucial for effective clinical decision-making and patient peace of mind. The processing of Liver Function Tests is carried out using automated, high-throughput analyzers that ensure rapid turnaround times. Typically, LFT reports are finalized and verified by our consultant pathologists within 4 to 6 hours of sample collection. Patients and their referring physicians can access these reports online through the secure portal on the Biotech Lahore Lab website, via SMS notifications with direct download links, or by visiting the lab collection center in Lahore for a printed copy.

LFT-Liver Functions Tests Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Alanine Aminotransferase (ALT)	7 to 56 U/L	Elevated in acute/chronic hepatitis, fatty liver, drug-induced liver injury, or hepatic ischemia.
Aspartate Aminotransferase (AST)	10 to 40 U/L	Elevated in liver injury, myocardial infarction, muscle trauma, or active cirrhosis.
Alkaline Phosphatase (ALP)	44 to 147 U/L	Elevated in biliary obstruction, gallstones, bone disorders, or pregnancy.
Gamma-Glutamyl Transferase (GGT)	9 to 48 U/L	Elevated in biliary obstruction, alcohol abuse, cholestasis, or hepatotoxic drug use.
Total Bilirubin	0.3 to 1.2 mg/dL	Elevated in jaundice, biliary tract obstruction, hemolysis, or liver disease.
Direct (Conjugated) Bilirubin	0.0 to 0.3 mg/dL	Elevated in biliary obstruction, hepatitis, cirrhosis, or inherited excretory defects.
Albumin	3.5 to 5.0 g/dL	Decreased in chronic liver disease, cirrhosis, malnutrition, or nephrotic syndrome.
Total Protein	6.0 to 8.3 g/dL	Decreased in liver synthetic failure; elevated in chronic inflammation or plasma cell disorders.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Biotech Lahore Lab for LFT-Liver Functions Tests?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists, clinical biochemists, and skilled phlebotomists dedicated to diagnostic excellence.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the testing process.
• Quality Diagnostic Services: Biotech Lahore Lab adheres to strict internal and external quality control protocols to ensure maximum accuracy.
• Professional Reporting: All diagnostic reports are thoroughly verified by consultant pathologists before release.
• Modern Diagnostic Approach: We utilize advanced clinical chemistry analyzers and automated systems for precise biomarker quantification.
• Comfortable Environment: Our collection centers in Lahore are designed to provide a clean, hygienic, and stress-free experience for patients.
• Convenient Location: Easily accessible facilities across Lahore make it simple for patients to undergo diagnostic testing.
• Commitment to Accurate Diagnosis: We are dedicated to providing reliable, evidence-based diagnostic insights to support your healthcare journey.